The Bureau of Economic Analysis will release the personal consumption expenditures, or PCE, price index for December on Friday at 8:30 a.m. ET, as part of its personal income and outlays report. Gold ...

Vasella stepped down as Novartis' CEO in January 2010 and was replaced ... In 2004, The Novartis Institute for Tropical Disease opened in Singapore, with a focus on biomedical research for dengue ...

Satya Nadella, Chairman and CEO of Microsoft, has topped the inaugural HSBC Hurun Global Indians List 2024, underlining his leadership in driving the company's global success.

Some of the prominent individuals featured on the list are Thomas Kurian, CEO of Google Cloud; Shantanu Narayen, Chairman and CEO of Adobe; and Vasant Narasimhan, CEO of Novartis. These leaders ...

CEO of Novartis. These leaders have been at the forefront of driving innovation in technology and healthcare within their respective companies. In an increasingly digital world, it is noteworthy ...

The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization ...

Swiss pharmaceutical giant Novartis said on Tuesday (Feb 11) it has agreed to acquire biopharma firm Anthos Therapeutics for ...

It also saw increased use in China and Japan for hypertension management. In an interview with CNBC, Novartis CEO Vas Narasimhan downplayed concerns about Entresto’s U.S. patent expiration ...

Data for December were not yet available. Kisqali is undergoing “a very rapid launch” in early breast cancer, Novartis CEO Vas Narasimhan said during a media call Friday. As Narasimhan shared ...

Novartis Q4 earnings beat estimates with sales up 16%, driven by strong demand for Entresto, Kesimpta, and Cosentyx. CEO Narasimhan reportedly downplays Entresto's U.S. patent expiration ...